Literature DB >> 31583615

Authors' Reply to K. Langdon and Colleagues' Comment on: "Botulinum Toxin in the Management of Children with Cerebral Palsy".

Iqbal Multani1, Jamil Manji1, Tandy Hastings-Ison2, Abhay Khot3, Kerr Graham4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31583615     DOI： 10.1007/s40272-019-00359-1

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN： 1174-5878            Impact factor:   3.022


× No keyword cloud information.
  13 in total

1.  Sagittal gait patterns in spastic diplegia.

Authors:  J M Rodda; H K Graham; L Carson; M P Galea; R Wolfe
Journal:  J Bone Joint Surg Br       Date:  2004-03

2.  Botulinum neurotoxin A, blinding, and bias.

Authors:  Tandy Hastings-Ison; Kerr Graham
Journal:  Dev Med Child Neurol       Date:  2019-06-21       Impact factor: 5.449

3.  Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy.

Authors:  Simon-Henri Schless; Francesco Cenni; Lynn Bar-On; Britta Hanssen; Barbara Kalkman; Thomas O'brien; Erwin Aertbeliën; Anja Van Campenhout; Guy Molenaers; Kaat Desloovere
Journal:  Dev Med Child Neurol       Date:  2018-10-15       Impact factor: 5.449

4.  The effects of botulinum toxin injection frequency on calf muscle growth in young children with spastic cerebral palsy: a 12-month prospective study.

Authors:  Lee Barber; Tandy Hastings-Ison; Richard Baker; H Kerr Graham; Rod Barrett; Glen Lichtwark
Journal:  J Child Orthop       Date:  2013-06-18       Impact factor: 1.548

5.  Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase.

Authors:  Jeanne Montastruc; Philippe Marque; Florence Moulis; Véronique Bourg; Valérie Lambert; Geneviève Durrieu; Jean-Louis Montastruc; François Montastruc
Journal:  Dev Med Child Neurol       Date:  2016-09-28       Impact factor: 5.449

6.  Comment on: "Botulinum Toxin in the Management of Children with Cerebral Palsy".

Authors:  Katherine Langdon; Lisa Copeland; Priya Edwards; Kate Rodwell; Kim McLennan; Theresa Carroll; Sasaka Bandaranayake; Adam Scheinberg; Mary-Clare Waugh; Heather Burnett; Neil Wimalasundera; Sabine Hennel; Eewei Lim; Steve O'Flaherty
Journal:  Paediatr Drugs       Date:  2019-12       Impact factor: 3.022

7.  Botulinum toxin and surgical intervention in children and adolescents with cerebral palsy: who, when and why do we treat?

Authors:  Jane Valentine; Sue-Anne Davidson; Natasha Bear; Eve Blair; Roslyn Ward; Ashleigh Thornton; Katherine Stannage; Linda Watson; David Forbes; Catherine Elliott
Journal:  Disabil Rehabil       Date:  2019-08-15       Impact factor: 3.033

Review 8.  A systematic review of interventions for children with cerebral palsy: state of the evidence.

Authors:  Iona Novak; Sarah McIntyre; Catherine Morgan; Lanie Campbell; Leigha Dark; Natalie Morton; Elise Stumbles; Salli-Ann Wilson; Shona Goldsmith
Journal:  Dev Med Child Neurol       Date:  2013-08-21       Impact factor: 5.449

9.  Onabotulinum toxin-A (Botox) for spastic equinus in cerebral palsy: a prospective kinematic study.

Authors:  T Hastings-Ison; M Sangeux; P Thomason; B Rawicki; M Fahey; H K Graham
Journal:  J Child Orthop       Date:  2018-08-01       Impact factor: 1.548

Review 10.  Botulinum Toxin in the Management of Children with Cerebral Palsy.

Authors:  Iqbal Multani; Jamil Manji; Tandy Hastings-Ison; Abhay Khot; Kerr Graham
Journal:  Paediatr Drugs       Date:  2019-08       Impact factor: 3.022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.